The Home of the Life Sciences Industry

Explore Latest News

FDA Approves Novartis' Adakveo for Pain Events Associated with Sickle Cell Disease

“The approval of Adakveo marks a new era in the treatment of sickle cell disease, a genetic condition that places an extraordinary burden of unpredictable pain crises on patients and their families,” said Susanne Schaffert, president of Novartis Oncology.

Heart Failure Drug Developed by Merck and Bayer Meets Endpoints in Phase III Trial

The results of the Phase III VICTORIA trial set up the potential for the companies to seek regulatory approval for vericiguat.

Get personalized job alerts

Create a job alert and receive custom job recommendations straight to your inbox.

Employers

Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.

Post Jobs Now